Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study

Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study

Background/aim: Respiratory and peripheral muscle strength are reduced in chronic obstructive pulmonary disease (COPD). There isa well-known correlation between handgrip strength (HGS) and strenght extremity muscles. Our aim in this study was to measure HGSand investigate the related factors in COPD patients with exacerbation.Materials and methods: Subjects with COPD exacerbation (n = 101) and stable COPD (n = 22), and subjects without COPD (n = 201),were enrolled in this study. Age, sex, and body mass index were similar. HGS was measured using a Vigorimeter. Pulmonary functiontests and 6-min walk tests were performed.Results: The mean HGS was significantly lower in subjects with COPD exacerbation than those with stable COPD and subjects withoutCOPD. The mean HGS was similar between stable COPD and non-COPD subjects. The mean 6-min walk distance (6MWD) wassignificantly lower in subjects with COPD exacerbation than stable COPD. There was a significant correlation between HGS and 6MWDbut no correlation between HGS and pulmonary function tests.Conclusion: In subjects with COPD exacerbation, the HGS was lower than that of stable COPD patients, and this difference was notexplained by age, comorbidities, severity of obstruction, or smoking. Physical inactivity and steroid use during exacerbation might bepossible factors affecting HGS. HGS was moderately correlated with 6MWD in cases of exacerbation. It may be used as a measure ofmuscle performance in COPD exacerbation, especially when the 6-min walk test cannot be performed.

___

  • 1. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. International Journal of COPD 2008; 3: 637-658.
  • 2. Franssen FM, Broekhuizen R, Janssen PP, Wouters EF, Schols AM. Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training. Med Sci Sports Exerc 2005; 37: 2-9.
  • 3. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
  • 4. Zattara-Hartmann MC, Badier M, Guillot C, Tomei C, Jammes Y. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 1995; 18: 495-502.
  • 5. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-632.
  • 6. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc 2003; 51: 636-641.
  • 7. Ling CH, Taekema D, de Craen AJ, Gussekloo J, Westendorp RG, Maier AB. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ 2010; 182: 429-435.
  • 8. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
  • 9. Shah S, Nahar P, Vaidya S, Salvi S. Upper limb muscle strength & endurance in chronic obstructive pulmonary disease. Indian J Med Res 2013; 138: 492-496.
  • 10. Martinez CH, Diaz AA, Meldrum CA, McDonald MLN, Murray S, Kinney GL, Hokanson JE, Curtis JL, Bowler RP, Han MK et al. Handgrip strength in chronic obstructive pulmonary disease associations with acute exacerbations and body composition. Annals of the ATS 2017; 14: 1638-1645.
  • 11. Cortopassi F, Divo M, Pinto-Plata V, Celli B. Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients. Respir Med 2011; 105: 748-754.
  • 12. Dourado VZ, Antunes LC, Tanni SE, de Paiva SA, Padovani CR, Godoy I. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest 2006; 129: 551-557.
  • 13. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003; 123: 387-398.
  • 14. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care 2009; 54: 1040-1049.
  • 15. Richards L, Palmiter-Thomas P. Grip strength measurement: a critical review of tools, methods, and clinical utility. Critical Reviews in Physical and Rehabilitation Medicine 1996; 8: 1-2.
  • 16. Celli BR, Macnee W, Agusti A, Berg B, Buist AS, Calverley PMA, Chavannes N, Dillars T, Fahy B, Fein A et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23: 932-946.
  • 17. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428-1446.
  • 18. Vilaró J, Ramirez-Sarmiento A, Martínez-Llorens JM, Mendoza T, Alvarez M, Sánchez-Cayado N, Vega A, Gimeno E, Coronell C, Gea J et al. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med 2010; 104: 1896-1902.
  • 19. Heijdra YF, Pinto-Plata V, Frants R, Rassulo J, Kenney L, Celli BR. Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 2003; 124: 75-82.
  • 20. Ansari K, Keaney N, Taylor I, Burns G, Farrow M. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease. Postgrad Med J 2012; 88: 372-376.
  • 21. Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol 2013; 114: 1222-1234.
  • 22. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2001; 2: 216-224.
  • 23. Wouters EF. Muscle wasting in chronic obstructive pulmonary disease: to bother and to measure! Am J Respir Crit Care Med 2006; 173: 4-5.
  • 24. Rantanen T, Guralnik JM, Sakari-Rantala R, Leveille S, Simonsick EM, Ling S, Fried LP. Disability, physical activity, and muscle strength in older women: the Women’s Health and Aging Study. Arch Phys Med Rehabil 1999; 80: 130-135.
  • 25. Kaymaz D, Candemir İÇ, Ergün P, Demir N, Taşdemir F, Demir P. Relation between upper-limb muscle strength with exercise capacity, quality of life and dyspnea in patients with severe chronic obstructive pulmonary disease. Clin Respir J 2018; 12: 1257-1263.
  • 26. Sayer AA, Syddall HE, Martin HJ, Dennison EM, Roberts HC, Cooper C. Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing 2006; 35: 409-415.
  • 27. Sirguroh A, Ahmed S. Hand grip strength in patients with chronic obstructive pulmonary disease. Int J Curr Res Rev 2012; 4: 168.